Background:Herpes zoster (HZ) is typically characterized by a burning, stabbing pain, hyperalgesia, and allodynia. In some patients, despite the lesions resolving, the pain persists and becomes chronic. If the pain continues for more than 6 months after the onset of the pain phase, this condition is called postherpetic neuralgia (PHN). The frequency and severity of PHN increase with advancing age. The pain in PHN can be severe, sometimes resistant to medications, significantly impacting the patients’ quality of life. The elderly patient population cannot tolerate the medications due to their side effects. In this situation, interventional pain treatment should be applied in the elderly patient group who have a high risk of developing PHN compared to other age groups.Method:We included patients over 65 years of age with HZ‐related pain who underwent dorsal root ganglion (DRG) pulsed radiofrequency (PRF) within the first 6 months from the onset of pain. We divided these patients into 2 groups: patients who underwent intervention within the first 1 month from the onset of pain and patients who underwent intervention between 1 and 6 months. We recorded medication doses and Numeric Rating Scale (NRS) scores before the procedure and at 1 week, 1 month, 3 months, and 6 months after the procedure.Results:After the DRG PRF treatment, NRS scores improved significantly in both groups (p< 0.05). The mean NRS score in the early DRG PRF group was significantly lower than that in the late DRG PRF group (p< 0.05). The medication doses in the early DRG PRF group were significantly lower than those in the other group (p< 0.05).Conclusions: Interventional pain treatment should be applied as soon as possible in the elderly patient group who do not respond to first‐line medical treatment or cannot tolerate medical treatment due to its side effects and who have a high risk of developing PHN compared to other age groups. DRG PRF, applied in the early period of medical treatment‐resistant acute HZ, is safe and effective, preventing the progression to PHN.
Aim This study was carried out to evaluate the efficacy of CT-guided percutaneous cordotomy and postoperative complications in the treatment of intractable pain associated with lung cancer. Material &Method Computed tomography (CT) guided-cordotomy was performed on 10 lung cancer patients unresponsive to medical and interventional pain management methods. Results The mean pretreatment and post treatment visual analogue scale (VAS) scores of the patients were determined as 10 ± 0.0001 and 1.00 ± 0.67, respectively. Additionally, the mean pretreatment and posttreatment Karnofsky Performance Scale (KPS) scores of the patients were calculated as 40± 9.42 and 73±10.59, respectively. Accordingly, there was a statistically significant difference between the pretreatment and posttreatment VAS and KPS scores. Furthermore, the mean pretreatment and posttreatment morphine equivalent dose of the patients were found as 860.2±199.8 mg and 220.7±69.08 mg, respectively. Conclusion The findings of this study suggest that cordotomy is a valuable treatment option for intractable pain problems in patients suffering from lung cancer.
Background: Severe cancer-related pain remains a major clinical challenge in patients with advanced malignancies and may persist despite multimodal analgesic treatment. Objective: This study evaluated short-term clinical outcomes and complications associated with computed tomography (CT)-guided percutaneous cordotomy for severe, unilateral cancer-related pain. Design: This retrospective single-center case series included 21 patients with treatment-refractory cancer pain who underwent CT-guided cordotomy between 2019 and 2024. Pain intensity, functional status, and opioid consumption were assessed at baseline and at the standardized 1-month follow-up using the Visual Analog Scale (VAS), Karnofsky Performance Status (KPS), and daily morphine milligram equivalents (MME), respectively. Results: At 1 month, the mean VAS score decreased from 9.95 to 0.90 (p < 0.001), mean daily MME decreased from 876.00 to 205.62 mg/day (p < 0.001), and mean KPS increased from 38.10 to 69.52 (p < 0.001). No permanent or major complications were documented during the available 1-month follow-up. Conclusions: In this retrospective single-center case series, CT-guided percutaneous cordotomy was associated with marked short-term reductions in pain intensity and opioid requirements and improvement in functional status at 1 month in patients with severe, unilateral cancer pain refractory to conventional therapy. Given the small sample size, absence of a control group, and limited follow-up duration, these findings should be considered preliminary and should not be interpreted as establishing definitive efficacy or safety.